Bristol Myers Squibb (BMS)
Bristol Myers Squibb (BMS) is an American pharmaceutical company, headquartered in New York City.
Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
BMS’s primary R&D sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton), New Brunswick, New Jersey, and Redwood City, California; with other sites in Devens and Cambridge, Massachusetts, East Syracuse, New York, Braine-l’Alleud, Belgium, Tokyo, Japan, Bangalore, India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut (formerly Bristol-Myers).
Traded as: NYSE: BMY; S&P 100 component; S&P 500 component
Industry: Pharmaceuticals
Founded: 1887; 133 years ago
Founders: William McLaren Bristol; John Ripley Myers; E. R. Squibb
Headquarters: 430 East 29th Street New York City, New York, United States
Website: https://www.bms.com/
Bristol Myers Squibb to buy RayzeBio for $4.1 billion in cash
Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion
Bristol Myers Squibb announces 5.3% dividend increase
Bristol Myers Squibb Announces CEO Transition and New Board Chair
Bristol Myers Squibb completes acquisition of Forbius
Bristol-Myers Squibb to acquire Mirati Therapeutics for up to $5.8 billion
Sensyne Health signs research collaboration agreement with Bristol Myers Squibb
About The Author
